All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| pyrimidine ribonucleotide | CHEBI_26446 | |
| pyrimidine ribonucleoside 5'-monophosphate(2-) | CHEBI_138238 | [A nucleoside 5'-monophosphate(2-) obtained by deprotonation of the phospohate OH groups of any pyrimidine ribonucleoside 5'-monophosphate; major species at pH 7.3.] |
| CHEBI_60378 | CHEBI_60378 | |
| alkanal | CHEBI_60379 | [An aldehyde of formula CR3CHO, where at least one R group is not H.] |
| alpha-D-Galp-(1->3)-alpha-D-GlcpNAc | CHEBI_145589 | [An amino disaccharide composed of D-galactose and 2-acetamido-2-deoxy-alpha-D-glucopyranosyl residues in (alpha-1->3) linkage.] |
| N-acetyl-alpha-D-glucosamine | CHEBI_44278 | [An N-acetyl-D-glucosamine that has alpha-configuration at the anomeric centre.] |
| (R)-etodolac | CHEBI_60370 | [The R-enantiomer of etodolac. It is inactive, in contrast to the enantiomer, (S)-etodolac, which is a preferential inhibitor of cyclo-oxygenase 2 and a non-steroidal anti-inflammatory. The racemate is commonly used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain.] |
| etodolac | CHEBI_4909 | [A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.] |
| (S)-etodolac | CHEBI_60371 | [The S-enantiomer of etodolac. It is a preferential inhibitor of cyclo-oxygenase 2 and a non-steroidal anti-inflammatory, whereas the enantiomer, (R)-etodolac, is inactive. The racemate is commonly used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain.] |
| alpha-D-Manp-(1->3)-alpha-D-Manp-(1->3)-alpha-D-Manp-(1->3)-alpha-D-GlcpNAc | CHEBI_145585 | [An amino tetrasaccharide comprising three residues of D-mannose and one of N-acetyl-alpha-D-glucosamine, in a linear sequence, all joined by beta-(1->3)-linkages.] |
| 1-(3-O-sulfo-beta-D-galactosyl)sphingosine | CHEBI_60372 | [A sulfoglycosphingolipid that is sphingosine substituted on O-1 by a 3-O-sulfo-beta-D-galactosyl group; sulfatide in which one acyl chain has been removed by ozonolysis.] |
| sulfoglycosphingolipid | CHEBI_36477 | |
| 4-nitrophenyl alpha-D-galactoside | CHEBI_546840 | [An alpha-D-galactopyranoside having a 4-nitrophenyl substituent at the anomeric position.] |
| beta-D-Glcp-(1->6)-beta-D-Glcp-(1->3)-beta-D-Glcp | CHEBI_145586 | [A trisaccharide consisting of three molecules of beta-D-glucopyranose attached in sequence by (1->6) and (1->3) glycosidic linkages.] |
| lipid IVA oxoanion | CHEBI_60373 | [Any oxoanion formed by loss of one or more protons from the phosphate groups of a lipid IVA compound.] |
| beta-D-Galf-(1->5)-beta-D-Galf | CHEBI_145587 | [A beta-D-Galf-(1->6)-D-Galf which has beta configuration at the anomeric centre.] |
| beta-D-Galf-(1->6)-D-Galf | CHEBI_62354 | [A glycosylgalactose in which one D-galactofuranosyl residue is linked beta(1->6) to a second D-galactofuranose residue.] |
| 2-cis,6-cis-farnesyl diphosphate(3-) | CHEBI_60374 | [Trianion of 2-cis,6-cis-farnesyl diphosphate arising from deprotonation of the phosphate OH groups; major species at pH 7.3.] |
| 2-cis,6-cis-farnesyl diphosphate | CHEBI_19511 | |
| beta-D-GlcpA-(1->3)-beta-D-GalpNAc6S | CHEBI_145588 | [An oligosaccharide sulfate that is 2-acetamido-2-deoxy-6-O-sulfo-beta-D-galactopyranose in which the hydroxy group at position 3 has been converted to the corresponding beta-D-glucopyranuronoside.] |